UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Towards precision oncology in advanced prostate cancer

Nature reviews. Urology, 2019-11, Vol.16 (11), p.645-654

2019

Link zum Volltext

Verfügbarkeit prüfen

Clinical and molecular features of treatment‐related neuroendocrine prostate cancer

International journal of urology, 2018-04, Vol.25 (4), p.345-351

2018

Link zum Volltext

Verfügbarkeit prüfen

Small heat shock proteins in cancer therapy and prognosis

The international journal of biochemistry & cell biology, 2012-10, Vol.44 (10), p.1646-1656

2012

Link zum Volltext

Verfügbarkeit prüfen

Targeting the adaptive molecular landscape of castration‐resistant prostate cancer

EMBO molecular medicine, 2015-07, Vol.7 (7), p.878-894

2015

Link zum Volltext

Verfügbarkeit prüfen

Aggressive Variants of Castration-Resistant Prostate Cancer

Clinical cancer research, 2014-06, Vol.20 (11), p.2846-2850

2014

Link zum Volltext

Verfügbarkeit prüfen

Deep Docking: A Deep Learning Platform for Augmentation of Structure Based Drug Discovery

ACS central science, 2020-06, Vol.6 (6), p.939-949

2020

Link zum Volltext

Verfügbarkeit prüfen

Androgen Receptor Gene Aberrations in Circulating Cell-Free DNA: Biomarkers of Therapeutic Resistance in Castration-Resistant Prostate Cancer

Clinical cancer research, 2015-05, Vol.21 (10), p.2315-2324

2015

Link zum Volltext

Verfügbarkeit prüfen

The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate Cancer

Cell reports (Cambridge), 2015-08, Vol.12 (6), p.922-936

2015

Link zum Volltext

Verfügbarkeit prüfen

Circulating Tumor DNA Abundance and Potential Utility in De Novo Metastatic Prostate Cancer

European urology, 2019-04, Vol.75 (4), p.667-675

2019

Link zum Volltext

Verfügbarkeit prüfen

The Master Neural Transcription Factor BRN2 Is an Androgen Receptor-Suppressed Driver of Neuroendocrine Differentiation in Prostate Cancer

Cancer discovery, 2017-01, Vol.7 (1), p.54-71

2017

Link zum Volltext

Verfügbarkeit prüfen

Treatment Outcomes and Tumor Loss of Heterozygosity in Germline DNA Repair–deficient Prostate Cancer

European urology, 2017-07, Vol.72 (1), p.34-42

2017

Link zum Volltext

Verfügbarkeit prüfen

Neoadjuvant Enzalutamide Prior to Prostatectomy

Clinical cancer research, 2017-05, Vol.23 (9), p.2169-2176

2017

Link zum Volltext

Verfügbarkeit prüfen

Synergistic targeting of PI3K/AKT pathway and androgen receptor axis significantly delays castration-resistant prostate cancer progression in vivo

Molecular cancer therapeutics, 2013-11, Vol.12 (11), p.2342-2355

2013

Link zum Volltext

Verfügbarkeit prüfen

Activating AKT1 and PIK3CA Mutations in Metastatic Castration-Resistant Prostate Cancer

European urology, 2020-12, Vol.78 (6), p.834-844

2020

Link zum Volltext

Verfügbarkeit prüfen

Circulating Tumor DNA Genomics Correlate with Resistance to Abiraterone and Enzalutamide in Prostate Cancer

Cancer discovery, 2018-04, Vol.8 (4), p.444-457

2018

Link zum Volltext

Verfügbarkeit prüfen

Reproducibility and efficiency of serum-derived exosome extraction methods

Clinical biochemistry, 2014-09, Vol.47 (13-14), p.1286-1292

2014

Link zum Volltext

Verfügbarkeit prüfen

Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate Cancer

JNCI : Journal of the National Cancer Institute, 2017-12, Vol.109 (12)

2017

Link zum Volltext

Verfügbarkeit prüfen

Moving Towards Precision Urologic Oncology: Targeting Enzalutamide-resistant Prostate Cancer and Mutated Forms of the Androgen Receptor Using the Novel Inhibitor Darolutamide (ODM-201)

European urology, 2018-01, Vol.73 (1), p.4-8

2018

Link zum Volltext

Verfügbarkeit prüfen

LIN28B promotes the development of neuroendocrine prostate cancer

The Journal of clinical investigation, 2020-10, Vol.130 (10), p.5338-5348

2020

Link zum Volltext

Verfügbarkeit prüfen

Clusterin Mediates TGF-β-Induced Epithelial―Mesenchymal Transition and Metastasis via Twist1 in Prostate Cancer Cells

Cancer research (Chicago, Ill.), 2012-10, Vol.72 (20), p.5261-5272

2012

Link zum Volltext

Verfügbarkeit prüfen

Functional analysis of androgen receptor mutations that confer anti-androgen resistance identified in circulating cell-free DNA from prostate cancer patients

Genome Biology, 2016-01, Vol.17 (1), p.10-10, Article 10

2016

Link zum Volltext

Verfügbarkeit prüfen

High Fidelity Patient-Derived Xenografts for Accelerating Prostate Cancer Discovery and Drug Development

Cancer research (Chicago, Ill.), 2014-02, Vol.74 (4), p.1272-1283

2014

Link zum Volltext

Verfügbarkeit prüfen

Plasma miRNAs as biomarkers to identify patients with castration-resistant metastatic prostate cancer

International journal of molecular sciences, 2013-04, Vol.14 (4), p.7757-7770

2013

Link zum Volltext

Verfügbarkeit prüfen

Androgen deprivation promotes neuroendocrine differentiation and angiogenesis through CREB-EZH2-TSP1 pathway in prostate cancers

Nature communications, 2018-10, Vol.9 (1), p.4080-17, Article 4080

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 857

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(811)
Mit Volltextzugriff
(795)

Publikationsform

Sprache

Englisch
(855)
Japanisch
(174)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(547)
Life Sciences & Biomedicine
(512)
Humans
(484)
Male
(433)
Oncology
(262)
Prostate Cancer
(235)
Animals
(218)
Prostatic Neoplasms - Pathology
(208)
Mice
(181)
Biological And Medical Sciences
(175)
Medical Sciences
(171)
Urology & Nephrology
(170)
Cell Line, Tumor
(166)
Tumors
(155)
Prostatic Neoplasms - Metabolism
(123)
Prostatic Neoplasms - Genetics
(118)
Nephrology. Urinary Tract Diseases
(117)
Prostatic Neoplasms - Drug Therapy
(112)
Tumors Of The Urinary System
(110)
Urinary Tract. Prostate Gland
(109)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Cancer Research
(103)
Journal Of Clinical Oncology
(91)
Clinical Cancer Research
(48)
The Prostate
(41)
European Urology
(40)
Canadian Urological Association Journal
(24)
Molecular Cancer Therapeutics
(24)
Oncotarget
(23)
The Journal Of Urology
(22)
Bju International
(19)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Towards precision oncology in advanced prostate cancer

Clinical and molecular features of treatment‐related neuroendocrine prostate cancer

Small heat shock proteins in cancer therapy and prognosis

Targeting the adaptive molecular landscape of castration‐resistant prostate cancer

Aggressive Variants of Castration-Resistant Prostate Cancer

Deep Docking: A Deep Learning Platform for Augmentation of Structure Based Drug Discovery

Androgen Receptor Gene Aberrations in Circulating Cell-Free DNA: Biomarkers of Therapeutic Resistance in Castration-Resistant Prostate Cancer

The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate Cancer

Circulating Tumor DNA Abundance and Potential Utility in De Novo Metastatic Prostate Cancer

The Master Neural Transcription Factor BRN2 Is an Androgen Receptor-Suppressed Driver of Neuroendocrine Differentiation in Prostate Cancer

Treatment Outcomes and Tumor Loss of Heterozygosity in Germline DNA Repair–deficient Prostate Cancer

Neoadjuvant Enzalutamide Prior to Prostatectomy

Synergistic targeting of PI3K/AKT pathway and androgen receptor axis significantly delays castration-resistant prostate cancer progression in vivo

Activating AKT1 and PIK3CA Mutations in Metastatic Castration-Resistant Prostate Cancer

Circulating Tumor DNA Genomics Correlate with Resistance to Abiraterone and Enzalutamide in Prostate Cancer

Optimal sequencing of enzalutamide and abiraterone acetate plus prednisone in metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase 2, crossover trial

Reproducibility and efficiency of serum-derived exosome extraction methods

Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate Cancer

Moving Towards Precision Urologic Oncology: Targeting Enzalutamide-resistant Prostate Cancer and Mutated Forms of the Androgen Receptor Using the Novel Inhibitor Darolutamide (ODM-201)

LIN28B promotes the development of neuroendocrine prostate cancer

Clusterin Mediates TGF-β-Induced Epithelial―Mesenchymal Transition and Metastasis via Twist1 in Prostate Cancer Cells

Functional analysis of androgen receptor mutations that confer anti-androgen resistance identified in circulating cell-free DNA from prostate cancer patients

High Fidelity Patient-Derived Xenografts for Accelerating Prostate Cancer Discovery and Drug Development

Plasma miRNAs as biomarkers to identify patients with castration-resistant metastatic prostate cancer

Androgen deprivation promotes neuroendocrine differentiation and angiogenesis through CREB-EZH2-TSP1 pathway in prostate cancers

Suchergebnisse filtern